ddms has been researched along with n-hydroxy-n'-(4-butyl-2-methylphenyl)formamidine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, P; Edwards, PA; Falck, JR; Guo, M; Roman, RJ; Scicli, AG; Wygle, D | 1 |
Ao, Y; Cheng, H; Li, Y; Lv, X; Peng, R; Wan, J; Yang, J | 1 |
2 other study(ies) available for ddms and n-hydroxy-n'-(4-butyl-2-methylphenyl)formamidine
Article | Year |
---|---|
Inhibitors of cytochrome P450 4A suppress angiogenic responses.
Topics: Amides; Amidines; Animals; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Cornea; Cytochrome P-450 CYP4A; DNA, Complementary; Endothelium, Vascular; Enzyme Inhibitors; Fibroblast Growth Factor 2; Humans; Hydroxyeicosatetraenoic Acids; Male; Mitogens; Neovascularization, Pathologic; Polymerase Chain Reaction; Polymers; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sulfones; Umbilical Veins; Vascular Endothelial Growth Factor A | 2005 |
Cytochrome P450 omega-hydroxylase inhibition reduces cardiomyocyte apoptosis via activation of ERK1/2 signaling in rat myocardial ischemia-reperfusion.
Topics: Amides; Amidines; Animals; Apoptosis; Caspase 3; Cytochrome P-450 CYP4A; Enzyme Activation; Fatty Acids, Unsaturated; Hydroxyeicosatetraenoic Acids; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocardial Reperfusion Injury; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Signal Transduction; Sulfones | 2008 |